Systemic Lupus Erythematosus
📧 Sign up to get email alerts when something new happens for Systemic Lupus Erythematosus.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2023-10-13Clinical Trial Update: JMKX000189 for Moderate to Severe Active Systemic Lupus Erythematosus [Phase 2]
A Phase 2 clinical trial update for JMKX000189 in moderate to severe active systemic lupus erythematosus is reported with an unknown status.
-
CLINICAL_TRIALS trial_result · 2023-10-10Clinical Trial Update: Ascension® Post- Approval Study; PyroCarbon Metacarpophalangeal Total Joint Prosthesis [NA]
Clinical trial update for Ascension post-approval study reporting termination with results posted.
-
CLINICAL_TRIALS trial_result · 2023-09-29Clinical Trial Update: A Study to Assess the Safety, Tolerability, and Pharmacokinetics of E6742 in Systemic Lupus Erythematosus Participants [Phase 1, Phase 2]
A phase 1/2 clinical trial evaluating the safety, tolerability, and pharmacokinetics of E6742 in systemic lupus erythematosus has completed.
-
CLINICAL_TRIALS trial_result · 2023-09-22Clinical Trial Update: Efficacy and Safety of Four Doses of Cenerimod Compared to Placebo in Adult Subjects With Active Systemic Lupus Erythematosus [Phase 2]
A Phase 2 trial evaluating four doses of cenerimod versus placebo in adults with active systemic lupus erythematosus to assess efficacy and …
-
CLINICAL_TRIALS trial_result · 2023-09-21Clinical Trial Update: A Model About the Response of Belimumab in SLE [Phase 4]
Phase 4 trial update exploring belimumab in systemic lupus erythematosus.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2023-09-14Clinical Trial Update: Utilizing Qualitative and Quantitative Methods to Understand a New Model of Type 1 and 2 Systemic Lupus Erythematosus (SLE) [NA]
Clinical trial examining qualitative and quantitative methods to understand a new model of Systemic Lupus Erythematosus. Study completed wit…
-
CLINICAL_TRIALS trial_result · 2023-08-21Clinical Trial Update: Immunogenicity, Reactogenicity of Shingrix in SLE [Phase 3]
A Phase 3 trial update evaluating the immunogenicity and reactogenicity of Shingrix in patients with systemic lupus erythematosus (SLE).
-
CLINICAL_TRIALS trial_result · 2023-08-21Clinical Trial Update: Genomic Effects of Glucocorticoids in Patients With Systemic Lupus Erythematosus [EARLY_Phase 1]
This early-phase 1 study investigates the genomic effects of glucocorticoids in patients with systemic lupus erythematosus. Results have bee…
-
CLINICAL_TRIALS trial_result · 2023-07-21Clinical Trial Update: A Study to Investigate the Safety and Efficacy of Elsubrutinib and Upadacitinib Given Alone or in Combination in Participants With Moderately to Severely Active Systemic Lupus Erythematosus (SLE) [Phase 2]
Phase 2 trial evaluating safety and efficacy of elsubrutinib and upadacitinib alone or in combination in moderately to severely active syste…
-
CLINICAL_TRIALS trial_result · 2023-07-19Clinical Trial Update: Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Immunogenicity of Efavaleukin Alfa in Participants With Systemic Lupus Erythematosus [Phase 1]
Phase 1 clinical trial evaluating safety, tolerability, PK/PD, and immunogenicity of efavaleukin alfa in systemic lupus erythematosus has co…
-
CLINICAL_TRIALS trial_result · 2023-07-03Clinical Trial Update: Exploring the Therapeutic Effect of Telitacicept on Lupus Erythematosus Complicated With Thrombocytopenia [Phase 2]
Phase 2 trial update investigating telitacicept for systemic lupus erythematosus, including cases with thrombocytopenia.
-
CLINICAL_TRIALS trial_result · 2023-06-22Clinical Trial Update: Sequential Belimumab and T-cell Based Therapy in SLE [Phase 4]
Phase 4 clinical trial update investigating sequential belimumab followed by a T-cell based therapy for systemic lupus erythematosus (SLE).
-
CLINICAL_TRIALS trial_result · 2023-06-12Clinical Trial Update: Efficacy and Safety of Telitacicept in Early SLE [Phase 4]
Phase 4 clinical trial update evaluating telitacicept for systemic lupus erythematosus, focusing on efficacy and safety.
-
CLINICAL_TRIALS trial_result · 2023-05-16Clinical Trial Update: A Study of Baricitinib in Participants With Systemic Lupus Erythematosus (SLE) [Phase 3]
Phase 3 study of baricitinib in systemic lupus erythematosus was terminated; results posted in 2023.
-
CLINICAL_TRIALS trial_result · 2023-05-15Clinical Trial Update: Study to Evaluate BIIB059 (Litifilimab) in Cutaneous Lupus Erythematosus (CLE) With or Without Systemic Lupus Erythematosus (SLE) [Phase 2]
Phase 2 trial evaluating litifilimab (BIIB059) in cutaneous lupus erythematosus with or without systemic lupus erythematosus has completed a…
-
CLINICAL_TRIALS trial_result · 2023-05-12Clinical Trial Update: Acupressure for Fatigue in Systemic Lupus Erythematosus [NA]
A terminated clinical trial investigating acupressure for fatigue in systemic lupus erythematosus with posted results.
-
CLINICAL_TRIALS trial_result · 2023-05-11Clinical Trial Update: Study of Recombinant Human B Lymphocyte(RC18) Administered Subcutaneously to Subjects With Systemic Lupus Erythematosus(SLE) [Phase 3]
Phase 3 trial update for recombinant human B lymphocyte RC18 given subcutaneously in systemic lupus erythematosus has completed.
-
CLINICAL_TRIALS trial_result · 2023-03-30Clinical Trial Update: Etonogestrel Implants Protect Ovarian Reserve Function in Systemic Lupus Erythematosus [Phase 2, Phase 3]
A clinical trial update indicates etonogestrel implants are being studied for preserving ovarian reserve in systemic lupus erythematosus, sp…
-
CLINICAL_TRIALS trial_result · 2023-03-29Clinical Trial Update: Combined Pneumococcal Conjugate and Polysaccharide Vaccination in Inflammatory Rheumatic Disease [Phase 4]
A Phase 4 clinical trial evaluating combined pneumococcal conjugate and polysaccharide vaccination in adults with inflammatory rheumatic dis…
-
CLINICAL_TRIALS trial_result · 2023-03-20Clinical Trial Update: COVID-19 Vaccine in Immunosuppressed Adults With Autoimmune Diseases [Phase 3]
Phase 3 trial update for a COVID-19 vaccine studied in immunosuppressed adults with autoimmune diseases, currently completed.
-
CLINICAL_TRIALS trial_result · 2023-02-08Clinical Trial Update: Mesenchymal Stromal Cells (MSC´s) in Renal Lupus [Phase 2]
A Phase 2 clinical trial evaluating mesenchymal stromal cells for systemic lupus erythematosus and lupus glomerulonephritis.
-
CLINICAL_TRIALS trial_result · 2023-01-30Clinical Trial Update: A Study of Baricitinib (LY3009104) in Participants With Systemic Lupus Erythematosus [Phase 3]
Phase 3 trial of baricitinib in systemic lupus erythematosus was terminated; results posted.
-
CLINICAL_TRIALS trial_result · 2023-01-17Clinical Trial Update: COvid-19 Vaccine Booster in Immunocompromised Rheumatic Diseases [Phase 2, Phase 3]
A Phase 2/Phase 3 clinical trial update evaluating a COVID-19 vaccine booster in immunocompromised individuals with rheumatic diseases.
-
CLINICAL_TRIALS trial_result · 2023-01-17Clinical Trial Update: Use of Baricitenib to Maintain of Remission [Phase 2, Phase 3]
Clinical trial update for Baricitenib aimed at maintaining remission in lupus and nephritis in Phase 2/Phase 3.
-
CLINICAL_TRIALS trial_result · 2023-01-13Clinical Trial Update: Long Term Safety of Anifrolumab in Adult Subjects With Active Systemic Lupus Erythematosus [Phase 3]
A long-term safety update for anifrolumab in adults with active systemic lupus erythematosus (Phase 3) has completed with results posted.